Skip to content

13F-HR filed by Decheng Capital LLC

Decheng Capital LLC filed this 13F-HR for the quarter ended 2026-09-30, accepted by EDGAR 2026-11-13 22:27:10 UTC, with 11 holding rows worth $685,065,734.

Accession
0001104659-26-127247
Filed
2026-11-13
Accepted by EDGAR
Ingested
Source
EDGAR live feed

Original filing

13F report for Q3 2026

A holdings report, 11 entries on the cover page, a total value of $685,065,734 stated on the cover page (in dollars after the unit check, H1), rows summing to $685,065,734 with VALUE read as dollars as filed, 13F file number 028-23697. The quarter's positions are built on this report. The resolved quarter.

The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).

Issuer as filedCUSIPClassAmountValueValue read asType
CG ONCOLOGY INC156944100COMMON STOCK6,371,669$451,687,615dollars as filed
NUVATION BIO INC COM CL A67080N101Stock25,954,439$145,344,858dollars as filed
ACLARIS THERAPEUTICS INC COM00461U105Stock4,041,736$21,259,531dollars as filed
AARDVARK THERAPEUTICS INC002942100COM3,917,299$20,644,165dollars as filed
UPSTREAM BIO INC91678A107COMMON STOCK2,724,868$14,360,054dollars as filed
ARCUS BIOSCIENCES INC03969F109COM425,079$10,979,791dollars as filed
EQUILLIUM INC29446K106COM4,447,308$7,226,876dollars as filed
LYELL IMMUNOPHARMA INC55083R104COM692,050$6,775,170dollars as filed
ZENTALIS PHARMACEUTICALS INC98943L107COMMON STOCK1,323,327$3,665,616dollars as filed
BEYONDSPRING INCG10830100SHS3,065,702$2,360,591dollars as filed
PYXIS ONCOLOGY INC COMMON STOCK747324101Stock326,810$761,467dollars as filed

Amendment chain

FilingRoleFiledAcceptedIngested
13F-HR 0001104659-26-127247this filing2026-11-13